Camille L. Bedrosian - Chief Medical Officer at Amylyx Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
AMLX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Camille L. Bedrosian - trading volume in the past year for Amylyx Pharmaceuticals, Inc.

Holdings reported by Camille L. Bedrosian for Amylyx Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 182K $2.66M $14.58 Sep 30, 2025 Direct
Stock Option (Right to Buy) 103K Mar 6, 2025 Direct Common Stock

Transactions reported by Camille L. Bedrosian for Amylyx Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.